Geras Solutions has the possibility to decrease the clinical assessment time by over 50% through its Pre-Diagnosis tool”
- Göran Hagman
Neuro-Psychologist
Karolinska Hospital Memory Clinic
WE WILL SHORTLY BE RELEASING NEWS AND INFORMATION ON THE PROGRESS.
Pre Diagnosis
The Pre Diagnosis stage utilizes telemedicine to connect concerned users with dementia nurses and doctors to form a pre-diagnosis of the disease, utilizing amongst other standard tests and other gold-standard diagnostics used by the healthcare system. The Pre-Diagnosis gives an early indication of the disease to the user and creates a ‘database’ of test results to be used by the healthcare system during the formal diagnosis process, saving time and resources in the physical clinic.
Post Diagnosis
The Post Diagnosis features provides a practical toolkit for users diagnosed with dementia which help manage the disease and empower the user to take action to prevent further decay of mental health. Patients are able to consult with our certified dementia specialists and receive guidance relevant to disease management.
Contact us
Currently Geras is in the production phase of the first turnkey solution for the digital dementia space.
Geras app scientific note
The Geras Solutions app is based on scientifically validated methodologies for preventing and delaying the onset of dementia and equip the consumer and caregivers with knowledge based on the latest research outcomes.
The successful multidomain intervention developed in the FINGER study is the main inspiration for the app structure and content.The app allows users to proactively reduce their risk of developing dementia. They are able to use digital versions of gold-standard diagnostic tools in cognitive status screening and contact specialists in dementia treatment.
Users who already have a dementia diagnosis will have access to a practical toolkit to help them manage the disease and empower them to prevent further decay of cognitive functions.
Currently, trials are running in memory clinics with the purpose of clinically testing the app's tools prior to launch and scaling. Concurrent pilot studies will be run at several nursing homes internationally to further refine tools for caregivers.
References:
Kivipelto M, Solomon A Ahtiluoto S, Ngandu T, LehtisaloJ, Antikainen R, Backman L. Hanninen T, Jula A Laatikainen T, Lindstrom J, Mangialasche F, Nissinen A Paajanen T, Pajala S. Peltonen M, Rauramaa R, Stigsdotter-Neely A,Strandberg T, TuomilehtoJ, Soininen H. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013 Nov;9(6):657-65. doi: 10.1016/jjalz.2012.09.012.
Ngandu T, Lehtisolo J, Solomon A Levalahti 6 Ahtiluoto 5, Antikainen R, Backman L, Hanninen T, Jula A Laatikainen T, Lindstrom J, Mangialosche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-NeelyA Strandberg T, TuomilehtoJ, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomized controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/50140-6736(15)60461-5.
